Abstract
Although the psychological and physiological effects of nicotine have long suggested that nicotine exerts specific actions in the brain, the identification of neuronal nicotinic receptors (nAChRs) only began in the past few years with the development of molecular genetics. It is now clear that neuronal nAChRs form a family of highly heterogenous receptor subtypes, as evidenced by the number of genes encoding nAChR subunits, the diversity of immunopurified receptor proteins, and the multiple functional types of ligand-gated ion channels. Neuronal nAChRs have discrete localizations within the brain, and are involved in modulating neuronal firing and transmitter release. Cumulative evidence from animal and human studies indicates that nicotinic systems play a major role in higher cognitive functions and dysfunctions. In particular, the loss of cortical nAChRs is a neurochemical hallmark of Alzheimer (AD) and Parkinson (PD) diseases. In addition, nicotine improves memory and attention in AD and PD. Our recent studies using electrophysiological biochemical and behavioral approaches suggest that the prefrontal cortex is a major target site for the cognitive actions of nicotine.
Similar content being viewed by others
References
Alkondon M. and Albuquerque E. X. (1993) Diversity of nicotinic acetylcholine receptors in rat hippocampla neurons.J. Pharmacol. Exp. Ther. 265, 1455–1473.
Araujo D. M., Lapchak P. A., Robitaille Y., Gauthier S., and Quirion R. (1988) Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.J. Neurochem. 50, 1914–1923.
Arneric S. P. and William M. (1995) Neuronal nicotinic acetylcholine receptors: novel targets for CNS therapeutics, inPsychopharmacology: The Fourth Generation of Progress. Raven, New York.
Chalmers D. T., Dewar D., Graham D. I., Brooks D. N., and McCullooch J. (1990) Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.Proc. Natl. Acad. Sci. USA 87, 1352–1356.
Clarke P. B. S. (1992) The fall and rise of neuronal α-bungarotoxin binding proteins.Trends Pharmacol. Sci. 13, 407–413.
Clarke P. B. S., Schwartz R. D., Paul S. M., Pert C. B., and Pert A. (1985) Nicotinic binding in a rat brain: autoradiographic comparison of3H-nicotine and125I-α bungarotoxin.J. Neurosci. 5, 1307–1315.
Cole A. E., and Nicoll R. A. (1984) The pharmacology of cholinergic excitatory responses in hippocampal pyramidal cells.Brain Res. 305, 283–290.
Court J. A., Piggott M. A., Perry E. K., Barlow R. B., and Perry H. H. (1992) Age associated decline in high-affinity nicotine binding in human brain frontal-cortex does not correlate with the changes in choline-acetyltransferase activity.Neurosci. Res. Commun. 10, 125–133.
Flynn D. D., and Mash D. C. (1986) Characterization ofl-[3H] nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal.J. Neurochem. 47, 1948–1954.
Fuster J. M. (1989)The Prefrontal Cortex. Anatomy, Physiology and Neuropsychology of the Frontal Lobe. Raven, New York.
Granon S., Poucet B., Thinus-Blanc C., Changeux J.-P., and Vidal C. (1995) Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection, and effortful processing.Psychopharmacology 119, 139–144.
Hodges H., Allen Y., Sinden J., Lantos P. L., and Gray J. A. (1991) Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system. II. Cholinergic drugs as probes to investigate lesion-induced deficits and transplant-induced functional recovery.Neuroscience 45, 609–623.
Isseroff A., Rosvold H. E., Galkin T. W., and Goldman-Rakic P. S. (1982) Spatial memory impairments following damage to the mediodorsal nucleus of the thalamus.Brain Res. 232, 97–113.
Jones G. M. M., Sahakian B. J., Levy R., Warburton D. M., and Gray J. A. (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.Psychopharmacology 108, 485–494.
Knight R. T. (1994) Attention regulation and human prefrontal cortex, inMotor and Cognitive Functions of the Prefrontal Cortex (Thierry A. M., Glowinski J., Goldman-Rakic P. S., and Christen Y., eds), Springer Berlin, pp. 160–173.
Levin, E. D. (1992) Nicotinic systems and cognitive function.Psychopharmacology,108, 417–431.
Markowitsch H. J. (1982) Thalamic mediodorsal nucleus and memory: a critical evaluation of studies in animals and man.Neurosci. Biobehav. Rev. 6, 351–380.
McGurck S. R., Levin E. D., and Butcher L. L. (1991) Impairment of radial-arm maze performance in rats following lesions involving the cholinergic medial pathway: reversal by alrecoline and differential effects of muscarinic and nicotinic antagonists.Neuroscience,44, 137–147.
Meyer E. M., Arendash G. W., Judkins J. H., Ying L., Wade C., and Rem W. R. (1987) Effects of nucleus basalis lesions on the muscarinic and nicotinic modulation of [3H]acetylcholine release in the rat cerebral cortex.J. Neurochem. 49, 1758–1762.
Miner L. L., Marks M. J., and Collins A. C. (1986) Genetic analysis of nicotine-induced seizines and hippocampal nicotinic receptors in the mouse.J. Pharmacol. Exp. Ther. 239, 853–860.
Muir J. L., Everitt B. J., Robbins T. W. (1995) Reversal of visual attentional dysfunction following AMPA-induced lesions of the basal forebrain by systemic administration of physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron, using a 5-choice serial reaction test (in press).
Newhouse P., Sunderland T., Tariot P., Blumhardt C. L., Weingartner H., Mellow A., and Murphy D. L. (1988) Intravenous nicotine in Alzheimer's disease: a pilot study.Psychopharmacology,95, 171–175.
Newhouse P., Sunderland T., Narang P., Mellow A. M., Fertig J., and Lawlor B. A., Murphy D. L. (1990) Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in non-smoking healthy volunteers and patients with Alzheimer's disease.Psychoneuroendocrinology 15, 471–484.
Nordberg A., and Winblad B. (1986) Reduced number of3H-nicotine and3H-acetylcholing binding sites in the frontal cortex of Alzheimer brains.Neurosci. Lett. 72, 115–119.
Olton D. S., Wenk G., Church R. M., and Meck W. H. (1988) Attention and the frontal cortex as examined by simultaneous temporal processing.Neuropsychologia 26, 307–318.
Pardo J. V., Fox P. T., and Raichle M. E. (1991) Localization of a human system for sustained attention by positron emission tomography.Nature,349, 61–64.
Perry E. K., Perry R. H., Smith C. J., Dick D. J., Candy J. M., Edwardson J. A., Fairbairn A., and Blessed G. (1987) Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.J. Neurol. Neurosurg. Psychiatry 50, 806–809.
Prusky G. T., Arbuckle J. M., and Cynader H. S. (1988) Transient concordant distributions of nicotinic receptors and acetylcholinesterase activity in infant rat visual cortex.Brain Res. 39, 154–159.
Rinne J. O., Myllykylä T., Lönnberg P., and Marjamäki P. (1991) A post-mortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease.Brain Res. 547, 167–170.
Role L. W. (1992) Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels.Curr. Opinions neurobiol. 2, 254–262.
Sahakian B., Jonnes G., Levy R., Gray J., and Warburton D. (1989) The effects of nicotine on attention, information processing and short-term memory in patients with dementia of Alzheimer type.Br. J. Psychiatry,154, 797–800.
Sahakian B., Owen A. M., Morant N. J., Eagger S. A., Boddington S., Crayton L., Crockford H. A., Crooks M., Hill K., and Levy R. (1993) Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB.Psychopharmacology 110, 395–401.
Sahin M., Bowen W. D., and Donoghue J. P. (1992) Location of nicotine and muscarinic cholinergic and mu-opiate receptors in rat cerebral neocortex: evidence from thalamic and cortical lesions.Brain Res. 579, 135–147.
Sargent P. B. (1992) The diversity of neuronal nicotinic acetylcholine receptors.Annu. Rev. Neurosci. 16, 403–443.
Schröder H., Zilles K., Maelicke A., and Hajos F. (1989) Immunohisto- and cytochemical localization of cortical nicotinic cholinoceptors in rat and man.Brain Res. 502, 287–295.
Schwartz R. D., Lehman J., and Kellar K. J. (1984) Presynaptic nicotinic cholinergic receptors labelled by [3H]acetylcholine on catecholamine and serotonin axons in brain.J. Neurochem. 42, 1495–1498.
Seguela P., Wadiche J., Dinelly-Miller K., Dani J. A., and Patrick J. W. (1993) Molecular cloning, functional properties and distribution of rat brain α7: a nicotinic action channel highly permeable to calcium.J. Neurosci,13, 596–604.
Snell L. D. and Johnson K. M. (1989) Effects of nicotinic agonists and antagonists onN-methyl-d-aspartate-induced3H-norepinephrine release and3H-(1-[1-(2-thienyl)cyclohexyl]-piperidine) binding in rat hippocampus.Synapse,3, 129–135.
Stokes K. A. and Best P. J. (1990) Response biases do not underlie the radial maze deficit in rats with mediodorsal thalamus lesions.Behav. Neurol. Biol. 53, 334–345.
Sugaya K. Giacobini E., and Chiappinelli V. A. (1990) Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease.J. Neurosci. Res. 27, 349–359.
Thierry A. M., Glowinsky J., Goldman-Rakic P. S., and Christen Y. (1994)Motor and Cognitive Functions of the Prefrontal Cortex. Springer Verlag, Berlin.
Vidal C. (1994) Nicotinic potentiation of glutamatergic synapses in the prefrontal cortex: new insight into analysis of the role of nicotinic receptors in cognitive functions.Drug Dev. Res. 31, 120–126.
Vidal C. and Changeux J. P. (1993) Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortexin vitro Neuroscience 56, 23–32.
Voytko M. L., Olton D. S., Richardson R. T., Gorman L. K., Tobin J. R., and Price D. L., (1994) Basal forebrain lesions in monkeys disrupt attention but not learning and memory.J. Neurosci. 14, 157–186.
Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., and Swanson L. W. (1989) Distribution of α2, α3, α4, and β2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat.J. Comp. Neurol. 284, 314–335.
Wevers A., Jeske A., Lobron Ch., Birtsch Ch., Heinemann S., Maelicke A., Schröder R., and Schröder H. (1994) Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization.Mol. Brain Res. 25, 122–128.
Whitehouse P. J., Marrtino A. M., Antuono P. G., Lowenstein P. R., Coyle J. T., Price D. L., and Kellar K. J. (1986) Nicotinic acetylcholine binding sites in Alzheimer's disease.Brain Res. 371, 146–151.
Wonnacott S., Drasdo A., Sanderson E., and Rowell P. (1990)Presynaptic Nicotinic Receptors and the Modulation of Transmitter Release, in the Biology of Nicotine Dependence. Ciba Foundation Symposium, Chichester, Wiley, pp. 87–105.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vidal, C. Nicotinic receptors in the brain. Molecular and Chemical Neuropathology 28, 3–11 (1996). https://doi.org/10.1007/BF02815199
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02815199